Nevertheless, MVA appears to be underutilised. 1 This may be due to a lack of awareness and confidence as the majority of earlier studies evaluating the efficacy of the procedure came from developing countries where electricity and surgical suites were not widely available. 1, 6 Moreover, in many cases where MVA was performed, 7 ultrasound guidance (USG) was not routinely used during the procedure.
Some women may prefer surgical evacuation to medical evacuation, particularly in cases of recurrent miscarriage where products of conception are more easily obtained for cytogenetic analysis. 7 In these cases, USG-MVA may be a preferred option.
MVA is gaining popularity in the UK and the USA. 8 However, the procedure remains largely unavailable in public hospitals within our locality (Hong Kong). We recently introduced USG-MVA in our unit as an option for management of first trimester missed or incomplete miscarriage.
MATERIAL AND METHODS

Patient selection
This study was carried out in the Obstetrics and Gynaecology
Department of the Prince of Wales Tertiary Hospital in Hong
Kong from July 2015 to October 2016. A consecutive series of 37 subjects who had missed miscarriage or incomplete miscarriage of <10 weeks of gestation and who wished to have cytogenetic examination of the products of conception to investigate the underlying cause of miscarriage were included in the study.
Patients who conceived naturally or with the use of assisted reproductive technology were included in the study. Gestational age was calculated using the last menstrual period, or for artificially conceived pregnancies, according to the time of ovulation, oocyte retrieval or embryo transfer. All women were given a choice of other alternative management options including expectant, medical and traditional surgical (dilatation and curettage under general anaesthesia) before providing informed consent for USG-MVA.
Missed miscarriage was defined as: (i) a lack of cardiac activity at crown rump length ≥5 mm; or (ii) an intrauterine gestational sac with a mean sac diameter of ≥20 mm without fetal pole; or (iii)
an intrauterine gestational sac ≤20 mm with no interval growth or persistent absence of fetal cardiac pulsation on rescanning 7-10 days later. Incomplete miscarriage was defined as the passage of products of conception with residual products on ultrasound (homogenous intra-uterine dimension measuring ≥11 cm 2 -sagittal and transverse plane) 9 and/or if the patient had persisting symptoms (pain and / or bleeding).
Patients with uterine anomalies, cervical stenosis, multiple uterine fibroids with distortion of the cavity, suspected infection, abnormal coagulation profile, extreme anxiety leading to inability to tolerate a pelvic exam, suspected ectopic pregnancy, and those who were haemodynamically unstable were excluded. 
Outcome measures
USG-MVA procedure
USG-MVA was carried out as an outpatient day procedure according to a pre-defined protocol modified from Sharma et al. 4 All patients were given misoprostol 400 µg orally for cervical priming 2-3 h prior to the procedure and antibiotic prophylaxis (amoxicillin and clavulanate 1.2 g) 30 min prior to the procedure. For preemptive pain relief, 500 mg naproxen was given orally 1 h prior to the procedure. If the patient was allergic to non-steroidal antiinflammatory drugs, paracetamol or codeine was used instead.
In case of heavy bleeding or passage of products of conception, a pelvic examination and/or ultrasound would be performed to ensure that MVA was still indicated. The patients were not required to empty their bladder for the procedure.
USG-MVA was performed using a 60 mL charged syringe who had previously undergone oocyte retrieval were also asked to complete a separate VAS to retrospectively quantify their pain during the oocyte retrieval procedure. Patients were given a follow-up appointment 2-3 weeks after the procedure at which time a pregnancy test was performed to exclude persistent trophoblast or molar pregnancy.
Ethical considerations
All participants provided written consent for the study. 
Statistical analysis
All data were entered and analysed using the SPSS version 22.0 database (SPSS Inc., Chicago, IL, USA). Data were expressed as absolute numbers and percentages. Chi Square test was used for categorical variables while student t-test was used for continuous variables. Two-tailed P < 0.05 was considered to be significant.
RESULTS
A total of 37 women with first trimester miscarriage were recruited for USG-MVA during the study period. USG-MVA was performed in 35 cases in an out-patient setting. One patient had USG-MVA cancelled as the products of conception were expelled completely after cervical priming and the other could not tolerate speculum examination due to anxiety and was managed with conventional surgical evacuation under general anaesthesia.
The baseline characteristics, details of the miscarriage and MVA procedure of subjects who underwent USG-MVA procedure are summarised in Table 1 Table 3 .
DISCUSSION
USG-MVA was recently introduced in our unit as an alternative management option to traditional surgical curettage for managing early pregnancy loss. During implementation, routine USG was performed during the procedure. To our knowledge, this is the first reported study with the use of routine USG during MVA.
Efficacy
In this study, the complete evacuation rate of USG-MVA was 97.1%, which is comparable to the figure of 97.9% reported in a systemic review by Wen et al. 12 In addition, the complete evacuation rate achieved by MVA (97.9%) and EVA (97.5%) appeared similar. Our USG-MVA complete evacuation rate is also much higher than that of medical management (84%) as quoted in a randomised controlled trial by Zhang et al.
13
Feasibility
USG-MVA is a simple procedure which can be performed in an out-patient setting using a hand-held 60 mL syringe. It does not require any electricity and the instrument is easily portable. More importantly, the procedure can be performed using oral or topical analgesics and does not require general anaesthesia or use of an operating theatre. [1] [2] [3] [4] [5] There were no complications noted in our study and all patients were discharged within the same day.
Cost-effectiveness
MVA reduces waiting time, hospital stay and the overall treatment cost. 4, 14 In our locality, the Med Gyn MVA kit costs approximately 
Patient acceptability
Our USG-MVA procedure was tolerated well by our patients.
Overall, all the patients were satisfied with the procedure and more than 80% would recommend the USG-MVA to their friends if they were to have a similar condition. Among 18 subjects who underwent oocyte retrieval in the past, the pain experienced was similar although it is acknowledged that these results may be affected by recall bias. Careful case selection is the key to successful USG-MVA and subjects who have a low pain threshold should not undergo this procedure. 4, 7, 16 Further randomised controlled trials are required to find the optimal pain relief regimen for patients undergoing USG-MVA.
Ultrasound guidance
Previously, MVA procedures were performed without the routine use of USG. In this study, we routinely used USG during the 
Chromosomal analysis
USG-MVA appears to be an ideal option for subjects who wish to conduct chromosomal analysis on the products of conception, such as patients with recurrent miscarriages or recurrent implantation failures. 
USG-MVA versus medical management
Our study showed that USG-MVA has a high success rate (97.1%)
in completing the evacuation process. It is achievable in an outpatient or office setting and is associated with a high degree of patient satisfaction. It therefore has many advantages over medical management, with the additional benefit of a high probability of obtaining successful cytogenic analysis from the products of conception (94.3% in our series) compared with the generally quoted success rate of approximately 80%. 8, 17 Women who wish to know if the index miscarriage is a consequence of aneuploidy, including those women who suffered from repeated losses or women who miscarried after in vitro fertilisation treatment, should consider USG-MVA. In our study, USG-MVA was at least as effective as medical management in completing the evacuation process based on the literature. 13 In this study we did not routinely obtain vaginal swabs for culture to screen for infection. Instead, we routinely administered antibiotic prophylaxis, although we acknowledge that the practice was not in accordance with current evidence as suggested by Cochrane reviews. 22 With the benefit of hind-sight, antibiotic therapy should only be offered to women with evidence of endometritis or sepsis, or in women with significant risk factors for infection (i.e. immunocompromised, poorly controlled diabetes).
We accept that USG-MVA, medical and surgical evacuation each have their own role in the management of first trimester miscarriage. For women who do not wish to have any cytogenetic analysis, medical evacuation may still be the first choice in the majority of cases as it is the least invasive. However, it may take days to weeks for the products of conception to be completely evacuated. In women who want cytogenetic analysis, timely evacuation and a higher successful evacuation rate than medical evacuation, USG-MVA should be considered.
Furthermore, blind suction evacuation should be largely replaced by USG-MVA.
A particular strength of our study was the prospective collection of data and the rigorous follow-up. However, a limitation of our study was the relatively small sample size.
In conclusion, our study showed that USG-MVA is an effective, feasible and acceptable treatment option for management of early pregnancy loss in an outpatient setting without the need for general anaesthesia. The current uptake of USG-MVA in our locality remains low. We hope that our study can raise the awareness and interest of USG-MVA in the management of early pregnancy loss.
